• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

Kiadis Pharma N.V.. (3/13/18). "Press Release: Kiadis Pharma Raises €23.4 Million in a Private Placement of 2.6 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction in which Unlawful]". Amsterdam.

	Organisation	Kiadis Pharma N.V. (Euronext: KDS)
	Group	Kiadis (Group)
	Organisation 2	Jefferies International Ltd.
	Group	Leucadia (Group)
	Product	ATIR101™ (Kiadis)
	Product 2	investment banking
	Index term	Kiadis–SEVERAL: investment, 201803 private placement €23.4m w 2.6m new shares €9/share to institutional investors
	Person	Lahr, Arthur (Kiadis 201704– CEO before Crucell 200701 Chief Strategy Officer + EP Sales + BusDev)
	Person 2	Hård, Karl (Kiadis 201709– Head IR + Communications before Redx Pharma 201610– Head of IR + CorpComm before AstraZeneca)

Record changed: 2018-03-31

Advertisement

More documents for Kiadis (Group)

• [1] Kiadis Pharma N.V.. (10/12/18). "Press Release: Kiadis Pharma Provides Regulatory and Clinical Update on ATIR101". Amsterdam....
• [2] Kiadis Pharma N.V.. (8/1/18). "Press Release: Kiadis Pharma Secures €20 Million Debt Financing Facility from Kreos Capital". Amsterdam....
• [3] Kiadis Pharma N.V.. (3/28/18). "Press Release: Kiadis Pharma on Track with European Regulatory Review for ATIR101. Responses Submitted to EMA Day 120 List of Questions". Amsterdam....
• [4] Kiadis Pharma N.V.. (3/14/18). "Press Release: Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference". Amsterdam....
• [5] Kiadis Pharma N.V.. (3/12/18). "Press Release: Kiadis Pharma Launches a Private Placement of Approximately 2.6 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction in which Unlawful]". Amsterdam....
• [6] Kiadis Pharma N.V.. (1/16/18). "Press Release: Kiadis Pharma Proposes Former Cipla CEO Subhanu Saxena as New Supervisory Board Member". Amsterdam-Duivendrecht....
• [7] Kiadis Pharma N.V.. (10/10/17). "Press Release: Kiadis Pharma Raises €18.0 Million in a Private Placement of 2.25 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Amsterdam-Duiv...
• [8] Kiadis Pharma N.V.. (10/9/17). "Press Release: Kiadis Pharma Launches a Private Placement of approximately 2.25 Million New Shares [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Amsterdam-Duive...
• [9] Kiadis Pharma N.V.. (9/27/17). "Press Release: Kiadis Pharma Provides Update on the Marketing Authorization Application Process for ATIR101 in Europe". Amsterdam-Duivendrecht....
• [10] Kiadis Pharma N.V.. (9/5/17). "Press Release: Kiadis Pharma Appoints Karl Hård as Head of Investor Relations and Communications". Amsterdam-Duivendrecht....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.